176 related articles for article (PubMed ID: 15850675)
1. From proteomics to biomarker discovery in Alzheimer's disease.
Ho L; Sharma N; Blackman L; Festa E; Reddy G; Pasinetti GM
Brain Res Brain Res Rev; 2005 Apr; 48(2):360-9. PubMed ID: 15850675
[TBL] [Abstract][Full Text] [Related]
2. Harnessing the power of gene microarrays for the study of brain aging and Alzheimer's disease: statistical reliability and functional correlation.
Blalock EM; Chen KC; Stromberg AJ; Norris CM; Kadish I; Kraner SD; Porter NM; Landfield PW
Ageing Res Rev; 2005 Nov; 4(4):481-512. PubMed ID: 16257272
[TBL] [Abstract][Full Text] [Related]
3. From cDNA microarrays to high-throughput proteomics. Implications in the search for preventive initiatives to slow the clinical progression of Alzheimer's disease dementia.
Pasinetti GM; Ho L
Restor Neurol Neurosci; 2001; 18(2-3):137-42. PubMed ID: 11847436
[TBL] [Abstract][Full Text] [Related]
4. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
[TBL] [Abstract][Full Text] [Related]
5. Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia.
Pasinetti GM
J Neurosci Res; 2001 Sep; 65(6):471-6. PubMed ID: 11550214
[TBL] [Abstract][Full Text] [Related]
6. Proteomics- and transcriptomics-based screening of differentially expressed proteins and genes in brain of Wig rat: a model for attention deficit hyperactivity disorder (ADHD) research.
Hirano M; Rakwal R; Shibato J; Sawa H; Nagashima K; Ogawa Y; Yoshida Y; Iwahashi H; Niki E; Masuo Y
J Proteome Res; 2008 Jun; 7(6):2471-89. PubMed ID: 18457438
[TBL] [Abstract][Full Text] [Related]
7. Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42).
Sultana R; Perluigi M; Butterfield DA
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 833(1):3-11. PubMed ID: 16236561
[TBL] [Abstract][Full Text] [Related]
8. Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models.
Reddy PH; McWeeney S
Neurobiol Aging; 2006 Aug; 27(8):1060-77. PubMed ID: 16157420
[TBL] [Abstract][Full Text] [Related]
9. [Preparation of the cDNA microarray on the differential expressed cDNA of senescence-accelerated mouse's hippocampus].
Cheng XR; Zhou WX; Zhang YX
Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):457-64. PubMed ID: 16755927
[TBL] [Abstract][Full Text] [Related]
10. Both plasma retinol-binding protein and haptoglobin precursor allele 1 in CSF: candidate biomarkers for the progression of normal to mild cognitive impairment to Alzheimer's disease.
Jung SM; Lee K; Lee JW; Namkoong H; Kim HK; Kim S; Na HR; Ha SA; Kim JR; Ko J; Kim JW
Neurosci Lett; 2008 May; 436(2):153-7. PubMed ID: 18378077
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease.
Lee JW; Namkoong H; Kim HK; Kim S; Hwang DW; Na HR; Ha SA; Kim JR; Kim JW
BMC Neurol; 2007 Jun; 7():14. PubMed ID: 17565664
[TBL] [Abstract][Full Text] [Related]
12. Targeted proteomics in Alzheimer's disease: focus on amyloid-beta.
Portelius E; Zetterberg H; Gobom J; Andreasson U; Blennow K
Expert Rev Proteomics; 2008 Apr; 5(2):225-37. PubMed ID: 18466053
[TBL] [Abstract][Full Text] [Related]
13. Recent cerebrospinal fluid biomarker studies of Alzheimer's disease.
Choi YS; Choe LH; Lee KH
Expert Rev Proteomics; 2010 Dec; 7(6):919-29. PubMed ID: 21142892
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects.
Cedazo-Minguez A; Winblad B
Exp Gerontol; 2010 Jan; 45(1):5-14. PubMed ID: 19796673
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease cerebrospinal fluid biomarker discovery: a proteomics approach.
D'Ascenzo M; Relkin NR; Lee KH
Curr Opin Mol Ther; 2005 Dec; 7(6):557-64. PubMed ID: 16372405
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ
Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307
[TBL] [Abstract][Full Text] [Related]
17. The role of proteomics in dementia and Alzheimer's disease.
Zellner M; Veitinger M; Umlauf E
Acta Neuropathol; 2009 Jul; 118(1):181-95. PubMed ID: 19259691
[TBL] [Abstract][Full Text] [Related]
18. Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain.
Butterfield DA
Brain Res; 2004 Mar; 1000(1-2):1-7. PubMed ID: 15053946
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment.
Mangialasche F; Polidori MC; Monastero R; Ercolani S; Camarda C; Cecchetti R; Mecocci P
Ageing Res Rev; 2009 Oct; 8(4):285-305. PubMed ID: 19376275
[TBL] [Abstract][Full Text] [Related]
20. An update on clinical proteomics in Alzheimer's research.
Korolainen MA; Nyman TA; Aittokallio T; Pirttilä T
J Neurochem; 2010 Mar; 112(6):1386-414. PubMed ID: 20050976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
